Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
説明
<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>The St Gallen International Expert Consensus 2011 has proposed a new classification system for breast cancer. The purpose of this study was to elucidate the relationship between the breast cancer subtypes determined by the new classification system and genomic characteristics.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Invasive breast cancers (n = 363) were immunohistochemically classified as follows: 111 (30.6%) as luminal A, 95 (26.2%) as luminal B (HER2 negative), 69 (19.0%) as luminal B (HER2 positive), 41 (11.3%) as HER2, and 47 (12.9%) as basal-like subtypes.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>The high expression of Ki-67 antigen was detected in 236 tumors; no cases of luminal A subtype showed high expression of the Ki-67 antigen, but more than 85% of tumors of the other subtypes showed high expression. In addition, DNA ploidy and chromosomal instability (CIN) were assessed using imaging cytometry and FISH, respectively. In this series, 336 (92.6%) tumors consisted of 129 diploid/CIN- and 207 aneuploid/CIN + tumors. Diploid/CIN- and aneuploid/CIN+ features were detected in 64.9% and 27.9% of luminal A, 41.1% and 49.5% of luminal B (HER2-), 11.6% and 81.2% of luminal B (HER2+), 4.9% and 90.2% of HER2, and 17.0% and 76.6% of basal-like subtypes, respectively. Unlike the luminal B (HER2+), HER2 and basal-like subtypes, the luminal A and luminal B (HER2-) subtypes were heterogeneous in terms of DNA ploidy and CIN.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>It is reasonable to propose that the luminal A and luminal B (HER2-) subtypes should be further divided into two subgroups, diploid/CIN- and aneuploid/CIN+, based on their underlying genomic status.</jats:p> </jats:sec>
収録刊行物
-
- BMC Research Notes
-
BMC Research Notes 5 (1), 2012-07-25
Springer Science and Business Media LLC
- Tweet
キーワード
- Adult
- Science (General)
- Genotype
- QH301-705.5
- Receptor, ErbB-2
- Breast Neoplasms
- Q1-390
- Chromosomal Instability
- Humans
- Biology (General)
- In Situ Hybridization, Fluorescence
- Aged
- Cell Proliferation
- Medicine(all)
- Biochemistry, Genetics and Molecular Biology(all)
- Genome, Human
- R
- DNA, Neoplasm
- Middle Aged
- Aneuploidy
- Immunohistochemistry
- Neoplasm Proteins
- Ki-67 Antigen
- Medicine
- Female
- Neoplasm Grading
- Research Article
詳細情報 詳細情報について
-
- CRID
- 1360565168934222336
-
- ISSN
- 17560500
-
- PubMed
- 22830453
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE